Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice. [electronic resource]
Producer: 20190403Description: 70-76 p. digitalISSN:- 0040-3660
- Benzoates -- adverse effects
- Blood Platelets -- cytology
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Hydrazines -- adverse effects
- Male
- Middle Aged
- Platelet Count
- Purpura, Thrombocytopenic, Idiopathic -- blood
- Pyrazoles -- adverse effects
- Receptors, Fc -- therapeutic use
- Receptors, Thrombopoietin -- agonists
- Recombinant Fusion Proteins -- adverse effects
- Thrombopoietin -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.